EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Selective bacteriophages reduce the emergence of resistant bacteria in bacteriophage-antibiotic combination therapy

Aa Haeruman Azam iD, Koji Sato, Kazuhiko Miyanaga, Tomohiro Nakamura, Shinjiro Ojima, Kohei Kondo, Azumi Tamura, Wakana Yamashita, Yasunori Tanji iD, Kotaro Kiga iD

Microbiology Spectrum · 2024

DOI: 10.1128/spectrum.00427-23 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microbiology Spectrum, 2024. Verfasst von Aa Haeruman Azam und 9 weiteren Autor:innen. Beteiligte Einrichtung: Therapeutic Drugs and Vaccine Development Research Center, National Institute of Infectious Diseases, Toyama-ku, Shinjuku, Tokyo, Japan. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Escherichia coli O157, Escherichia coli Infections, Fosfomycin. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Agency for Medical Research and Development (AMED).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Escherichia coli O157:H7 is a globally important foodborne pathogen with implications for food safety. Antibiotic treatment for O157 may potentially contribute to the exacerbation of hemolytic uremic syndrome, and the increasing prevalence of antibiotic-resistant strains necessitates the development of new treatment strategies. In this study, the bactericidal effects and resistance development of antibiotic and bacteriophage monotherapy were compared with those of combination therapy against O157. Experiments involving continuous exposure of O157 to phages and antibiotics, along with genetic deletion studies, revealed that the deletion of glpT and uhpT significantly increased resistance to fosfomycin. Furthermore, we found that OmpC functions as a receptor for the PP01 phage, which infects O157, and FhuA functions as a receptor for the newly isolated SP15 phage, targeting O157. In the glpT and uhpT deletion mutants, additional deletion in ompC , the receptor for the PP01 phage, increased resistance to fosfomycin. These findings suggest that specific phages may contribute to antibiotic resistance by selecting the emergence of gene mutations responsible for both phage and antibiotic resistance. While combination therapy with phages and antibiotics holds promise for the treatment of bacterial infections, careful consideration of phage selection is necessary. IMPORTANCE The combination treatment of fosfomycin and bacteriophages against Escherichia coli O157 demonstrated superior bactericidal efficacy compared to monotherapy, effectively suppressing the emergence of resistance. However, mutations selected by phage PP01 led to enhanced resistance not only to the phage but also to fosfomycin. These findings underscore the importance of exercising caution in selecting phages for combination therapy, as resistance selected by specific phages may increase the risk of developing antibiotic resistance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anti-Bacterial AgentsEscherichia coli O157Escherichia coli InfectionsFosfomycinHumansDrug Resistance, BacterialBacteriophagesPhage TherapyColiphagesEscherichia coli Proteins

Stichwörter der Autor:innen

O157:H7antimicrobialsbacteriophage therapydiarrheadrug resistance evolutiondrug resistance mechanismsfosfomycingut microbiotaouter membrane proteins

Substanzen

Anti-Bacterial AgentsFosfomycinEscherichia coli Proteins

Autor:innen und Institutionen

  • Therapeutic Drugs and Vaccine Development Research Center, National Institute of Infectious Diseases, Toyama-ku, Shinjuku, Tokyo, Japan.
  • School of Life Science and Technology, Tokyo Institute of Technology, Nagatsutacho, Yokohama, Japan.
  • Division of Bacteriology, Department of Infection and Immunity, Jichi Medical University, Shimotsukeshi, Tochigi, Japan.

ORCID-Profile: Aa Haeruman Azam, Yasunori Tanji, Kotaro Kiga

Förderung

  • Japan Agency for Medical Research and Development (AMED)

Zitieren

APA

Azam, A. H., Sato, K., Miyanaga, K., Nakamura, T., Ojima, S., Kondo, K., Tamura, A., Yamashita, W., Tanji, Y., & Kiga, K. (2024). Selective bacteriophages reduce the emergence of resistant bacteria in bacteriophage-antibiotic combination therapy. Microbiology Spectrum. https://doi.org/10.1128/spectrum.00427-23

Vancouver

Azam AH, Sato K, Miyanaga K, Nakamura T, Ojima S, Kondo K, et al. Selective bacteriophages reduce the emergence of resistant bacteria in bacteriophage-antibiotic combination therapy. Microbiology Spectrum. 2024. doi:10.1128/spectrum.00427-23

BibTeX
@article{Azam2024,
  author = {Azam, Aa Haeruman and Sato, Koji and Miyanaga, Kazuhiko and Nakamura, Tomohiro and Ojima, Shinjiro and Kondo, Kohei and Tamura, Azumi and Yamashita, Wakana and Tanji, Yasunori and Kiga, Kotaro},
  title = {Selective bacteriophages reduce the emergence of resistant bacteria in bacteriophage-antibiotic combination therapy},
  journal = {Microbiology Spectrum},
  year = {2024},
  doi = {10.1128/spectrum.00427-23}
}
Kostenlos starten →